Drug Database
Back to search

Netherlands· NL-57a75296a60d

MultiHance, oplossing voor injectie 529 mg/ml, 5 ml, 10 ml, 15 ml en 20 ml

A gadobensäure product containing gadobenaat dimeglumine, registered in Netherlands by Bracco Imaging Deutschland GmbH. The same ATC class is registered in 9 of our 19 countries.

ATC V08CA08

Checked against CBG-MEB (Netherlands) on

Informational only — not a medical device.

SOURCE REGISTER · NLCBG-MEB (Netherlands)normalisedMultiHance, oplossing voor injectie 5…ATCV08CA08REGISTER NO.NL-57a75296a60dPACKS LISTED1CHECKEDSeptember 29, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about gadobenaat dimeglumineAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Gadobensäure is registered in 9 of 19 countries.

Countries holding a registration under ATC V08CA08 (gadobensäure), each read from that country’s own register.

  • This record: Netherlands, from CBG-MEB (Netherlands)
  • 5 of them publish a price we can compare per daily dose
Search gadobensäure products by name

Gadobensäure · ATC V08CA08

9 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

CBG-MEB (Netherlands)
Active substance
GADOBENAAT DIMEGLUMINE
Manufacturer
Bracco Imaging Deutschland GmbH
Country
Netherlands (NL)
ATC code
V08CA08
ATC class
Gadobensäure
Reimbursed
Not published by this register
Source register
CBG-MEB (Netherlands)
Last checked
September 29, 2026

Packs & prices · 1

  • cbg_meb_id
    22324

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same class

Other records under V08CA08

Gadobensäure, as other registers publish it.

All gadobensäure products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/f02866e5-28e7-46bd-b4a0-af768bc72807
GET /v1/drugs/f02866e5-28e7-46bd-b4a0-af768bc72807?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Oplossing voor injectie",
  "route": "Intraveneus gebruik",
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h22324_smpc.pdf",
  "strength": null,
  "atc_label": "Gadobenic Acid",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg22324",
  "excipients": [
    "WATER VOOR INJECTIE"
  ],
  "substances": [
    "GADOBENAAT DIMEGLUMINE"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h22324.pdf",
  "authorised_at": "1998/07/06",
  "procedure_number": "DE/H/5991/001",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "22324",
  "additional_monitoring": "N"
}
API referenceMCP serverPlans

See everything about gadobensäure.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console